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D
oug Hilton found his home in 
science as an undergraduate, 
when he took a summer job in 
Canberra, Australia that introduced him 
to the biology of blood cells. It’s a vast 
subject, but Hilton has explored much of 
it: from the cytokines that control blood 
cell differentiation (1) to the receptors 
that bind those cytokines (2), the signals 
those receptors set off within cells (3, 4), 
and the feedback mechanisms that help to 
regulate them (5).
As a graduate student with Nick Nicola, 
Hilton worked to identify factors con-
trolling blood cell growth—a project 
that unexpectedly led to the identifi  ca-
tion of leukemia inhibitory factor, or 
LIF (1). After a two-year postdoctoral 
stint studying the erythropoietin recep-
tor with Harvey Lodish at MIT (2), Hil-
ton returned home to Australia. There, a 
search for factors regulating cytokine 
signaling uncovered the suppressor of 
cytokine signaling (SOCS) family pro-
teins (3, 4).
Having recently been 
appointed Director of the 
Walter and Eliza Hall Insti-
tute in Melbourne, Hilton 
put off adding the fi  nishing 
touches to his new offi  ce 
to talk with us about his 
career, and his scientific 
and personal interests.
HOME EARLY
You’ve spent most of your career in 
Australia?
I suppose I haven’t ever strayed too far 
from home. [laughs] I still live in the town 
in which I grew up—although I did live 
abroad for two years while I did my postdoc 
at MIT. But I’ve always been comfortable 
here, a small suburb about 30 kilometers 
from the center of Melbourne.
It was quite early on in my career, 
too, that I found a research subject with 
which I felt at home. I’ve always been 
interested in the genes that regulate 
blood cell formation, even as a third-year 
student in college. I remember taking a 
laboratory job over summer vacation 
where I worked on the same types of 
questions that I’m still working on 25 
years later. I continue to fi  nd them fasci-
nating. My work has taken a few twists 
and turns, though. Early on my research 
focused on cytokines, their receptors, 
and signal transduction. Now I’m inter-
ested more generally in the genes that 
regulate blood cell production.
So right away as a graduate student, 
you knew what you wanted to do?
I completed my undergraduate studies 
at Monash University in Melbourne, 
and then switched to the University of 
Melbourne specifically to work in Nick 
Nicola’s laboratory because I wanted to 
study cytokines. I also ended up work-
ing pretty closely with Don Metcalf, 
whose laboratory abutted Nick’s, and 
with whom Nick collaborated closely. 
Don and Nick had just fi  nished purifying 
the cytokine G-CSF, a 
white blood cell growth 
factor. There was some 
uncertainty about how many 
other cytokines regulated 
blood cell production. So I 
trained as a protein chemist, 
and tried to identify these 
other factors. I ended up do-
ing chromatographic puri-
fi  cation of different factors, 
and that’s how we purifi  ed leukemia inhibi-
tory factor, or LIF.
LIF turned out to be a big deal, didn’t it?
Yes, but not for the reason we suspected. 
We purifi  ed it on the basis of its func-
tion on a particular blood-derived cell 
line. But as it turned out, the real excite-
ment around LIF is that it is the factor 
that stops mouse embryonic stem (ES) 
cells from differentiating, which allows 
you to manipulate them genetically in 
culture. The idea of looking at whether 
LIF might be responsible for keeping ES 
cells undifferentiated came about from a 
conversation at a meeting in Europe, 
between Nick Gough from Melbourne 
and Lindsay Williams from Heidelberg 
in Germany. They noticed that the way 
LIF eluted from an anion exchange col-
umn resembled a factor that Williams 
was trying to purify from embryonic 
stem cell lysates. Based on that rather 
tenuous possibility, we sent him some 
cloned recombinant LIF. His laboratory 
put it into their culture systems, and the 
rest is history.
HOME AWAY FROM HOME
How did you end up doing a postdoc 
with Harvey Lodish?
I suppose there was an expectation at that 
time in Australia that everybody should 
go abroad for their postdoc. He is obvi-
ously a fabulous protein chemist, and I 
thought his laboratory would be a good 
place to learn some molecular biology; 
I had trained almost exclusively as a 
protein chemist and didn’t know my way 
around a plasmid. I ended up with a 
couple of decent papers from my work 
there. But more than anything else, just 
working in his laboratory, in the environ-
ment of MIT, was eye opening for a 
small-town boy like me.
Hilton’s passion for blood makes his pulse race.
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How so?
Looking back, I think I was very young 
and naive. I remember walking into 
Harvey’s offi  ce on my fi  rst day. He said, 
“What do you want to work on?” And I 
was fl  oored because I hadn’t really given 
it that much thought.
I was sharing a bench with an older 
Israeli postdoc. He was a lovely guy, 
but every morning in my first five weeks 
I would come in and he would say to 
me, “What are you going to do?” I 
would give him an idea, and he would 
say, “That is rubbish.” 
[laughs] I eventually came 
up with some ideas, col-
laborated with the other 
postdocs, and ended up 
having a great time.
But you soon returned to 
Australia?
My wife and I had bought 
a house here before we 
went to Boston, so we had a 
home to come back to. I still wanted to 
work on the molecular regulation of blood 
cells, so I came back as a kind of junior 
laboratory head within Don Metcalf and 
Nick Nicola’s unit.
In Australia the tradition has been to 
make a gentle transition to running a 
laboratory. You can still collaborate 
with your mentors if you like; there’s no 
imperative to show you’re independent 
by working on a completely different 
problem. It’s a different way of doing 
things than other places, and I think 
people recognize that can be a good way 
to work. Initially Nick supported me on 
his grants, but when I returned I started 
bringing in more and more money and 
eventually became fi  nancially—and intel-
lectually—independent.
HOMING IN
This was when you identiﬁ  ed suppressor 
of cytokine signaling (SOCS)?
A lot of work had been done on the posi-
tive mediators of signal transduction, and 
we knew that while many cytokines are 
beneficial, they can produce some ill 
effects when they’re present in excess. 
So, we presumed there must be negative 
feedback signals that tempered cytokine 
action. I had a very talented postdoc, 
Robyn Starr, and we set out to identify them. 
Very quickly we pulled out an extraor-
dinarily powerful inhibitor of signaling 
and showed that it was part of a family of 
negative feedback regulator proteins. It 
was just one of those magic moments.
Since then, I’ve been lucky to continue 
with that story, which has turned out to 
have quite some depth to it. By homology 
we found eight members of the family 
that had SH-2 domains, and 
also this protein module at 
the C terminus that we 
named the SOCS box. 
Then we found a whole 
suite of other less-related 
molecules that also con-
tained a SOCS box, and we 
found that this domain is 
what couples these proteins 
to E3 ubiquitin ligases. 
The canonical SOCS pro-
teins seem to regulate virtually every 
cytokine that acts through the Jak/STAT 
pathway, which generated lots of interest 
from people in different subfields of 
cytokine action. It’s also taken us down 
some interesting paths; for example, we 
found that SOCS-2 regulates growth 
hormone signaling, so when we knocked 
it out the animals had gigantism.
What paths are you 
taking now?
In my laboratory, we’re 
working on three or four 
genes that are related to 
some pretty severe stem 
cell defects. At least one 
of these genes regulates 
Jak/STAT signaling, which 
is taking us back to cy-
tokine signaling again. 
We’re also interested in 
transcriptional networks 
that regulate lineage com-
mitment in stem cells.
Six months ago I was 
appointed Director of the 
Institute, which is located 
in the wonderful research precinct of 
Parkville near the center of Melbourne, 
so lately I’ve been occupied with that. 
But I am hoping things will soon settle 
down a little bit and let me get back to 
the laboratory some more. We’ll see what 
happens, after I come back from holiday 
with my family.
Where are you going on holiday?
My wife and I love to take our two kids 
out camping and hiking, so we’re taking 
a trip to do some of that. I like tramping 
about outdoors, partly because it lets me 
pursue my hobby, moth collecting. There 
are around 30,000 moth species in Aus-
tralia, and probably two thirds of them 
have never been described or even col-
lected. So I got these wonderful insect 
cabinets on loan from the National Insect 
Collection in Canberra. The idea is that 
I fi  ll the cabinets and when I die, they go 
back to the Collection. I bring my net 
and collecting kit with me on our family 
hikes, and I fairly often come back with 
something new.
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